SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity
Preprint in Research Square (May 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
SARS-CoV-2-ORF3a variant Q57H reduces its pro-apoptotic activity in host cells
Article in F1000Research (April 2024)
SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle
Article in Nature Communications (March 2024)